Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]
Jeong S, Seong SH, Sagong M.
europepmc +1 more source
Real World Data About the Treatment of Wet Age-Related Macular Degeneration in Kuopio University Hospital During 2019-2021 Using a PRN Regimen. [PDF]
Hiltunen TO, Kaarniranta K, Kivinen N.
europepmc +1 more source
Short-term efficacy of aflibercept 8 mg in refractory neovascular age-related macular degeneration: a retrospective case series from Taiwan. [PDF]
Chi SC +6 more
europepmc +1 more source
Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study. [PDF]
Berkowitz ST +8 more
europepmc +1 more source
Anti-vascular endothelial growth factor therapy for posterior segment diseases: Progress, challenges, and the road ahead. [PDF]
Mishra C +4 more
europepmc +1 more source
Real-World Outcomes of Aflibercept 2 mg Using a Treat-and-Extend Protocol for Neovascular Age-Related Macular Degeneration: A 24-Month Retrospective Study in a Chinese Population. [PDF]
Qi Y, Cheng A, Xu J, Zhang C, Li S.
europepmc +1 more source
Anti-vascular endothelial growth factors in retinal and choroidal diseases - Present landscape. [PDF]
Kannan NB +3 more
europepmc +1 more source
Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. [PDF]
Shi J +7 more
europepmc +1 more source
OCCLUSIVE RETINAL VASCULITIS AFTER AFLIBERCEPT 8 mg INJECTION FOR WET MACULAR DEGENERATION. [PDF]
Sisk RA.
europepmc +1 more source
Ikumi Kashiwagi, Ryota Nonaka, Shotaro Sasaki, Takuto Yamamoto, Kanako Yasuda, Masahiko Shimura Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, JapanCorrespondence: Masahiko Shimura, Department of ...
Kashiwagi I +5 more
doaj

